iiinova — where your digital self keeps evolving

Reposted by Zeynep Madak Erdogan

Keystone Symposia @keystonesymposia.bsky.social · 22/09/2026

Meet senior journal editors from @endocrinesociety.bsky.social at #KSHormoneInflu27 (Oct 5–8, Breckenridge) 15-min 1:1s with @zmadake2.bsky.social, JES Editor-in-Chief or Windy Boyd, Endo Society Journals' Executive Editor. 📱 Book next week via the KSConnect app—Open to all attendees + livestream

023

Reposted by Zeynep Madak Erdogan

Matt Sikora @mjsikora.bsky.social · 12/07/2025

If you're wondering, yes, @endocrinesociety.bsky.social will use your pictures for promo material 😂 #ENDO2025 Pretty cool to have @nrimpact.bsky.social folks featured: @profriggins.bsky.social @zmadake2.bsky.social @ayeshashafi.bsky.social @cittellylab.bsky.social Drs Cordoba-Chacon & Treviño

Photo of promotional displays, with a picture from the ENDO2024 poster session

Photo of the video banner over the registration booths, includes a photo from ENDO2024 of a group of faculty from the NR IMPACT group

0215

Reposted by Zeynep Madak Erdogan

Endocrine Society @endocrinesociety.bsky.social · 07/05/2025

Notice to Authors with the NIEHS Journal, Environmental Health Perspectives (EHP) | We welcome submissions or transfers of manuscripts now in process at EHP: #JES (Open Access, clinical and basic), and #Endocrinology (basic). Fees can be waived. Email publications@endocrine.org: bit.ly/2yCrRBi

bit.ly

Journals

Our top-ranked peer-reviewed journals are among the first to publish major developments and discovery milestones.

1104

Reposted by Zeynep Madak Erdogan

Matt Sikora @mjsikora.bsky.social · 02/01/2024

@jostrander.bsky.social and I had the opportunity to write a commentary on @profriggins.bsky.social latest work in JES - @zmadake2.bsky.social - looking toward really cool implications for understanding and leveraging the unique metabolism of lobular breast cancer. academic.oup.com/jes/advance-...

academic.oup.com

A path to precision metabolic treatment in breast cancer: riluzole, glutamate signaling, and invasiv...

Matthew J Sikora, Julie H Ostrander; A path to precision metabolic treatment in breast cancer: riluzole, glutamate signaling, and invasive lobular carcinoma, Jo

1134